# Rubicon Research Ltd (RUBICON)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹944.55
Day Change: -0.55%
52W High: ₹1013.4
52W Low: ₹570.75
Market Cap: ₹15,832 Cr

## Valuation
P/E: 76.94
P/B: 22.9
EPS: ₹12.49
Book Value: ₹41.96
Dividend Yield: 0%

## Returns
1Y Return: 45.14%

## Profitability
ROE: 16.82%
ROCE: 0%
Debt/Equity: 87.66
Revenue Growth: 51.7%
Profit Growth: 79.3%
EBITDA Margin: 22.31%
Operating Margin: 20.31%

## About
Rubicon Research Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: Rubicon Research Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') - Completion Of Acquisition Of Securities In Arinna Lifesciences Limited
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 2 more years.

## Data Freshness
Quote Updated: 2026-05-25T18:00:11.510Z
Price History Updated: 2026-05-25T05:29:24.580Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:29:24.580Z
Quant Updated: 2026-05-25T05:29:24.580Z
Sentiment Updated: 2026-05-25T05:29:24.580Z
Financials Status: stale
Financials Updated: 2026-05-18T08:30:01.877Z
Financials Last Attempt: 2026-05-18T08:30:01.877Z
Financials Provider Tried: database
Latest P&L Period: Mar 2021
Latest Balance Sheet Period: Mar 2021
Latest Cash Flow Period: Mar 2021

## P&L (Mar 2021)
Revenue: ₹263 Cr
Operating Profit: ₹81 Cr (OPM 31%)
Net Profit: ₹49 Cr
Tax: ₹74 Cr

## Annual P&L History
Mar 2021: Rev ₹263Cr | PAT ₹49Cr | OPM 31%
Mar 2022: Rev ₹315Cr | PAT ₹31Cr | OPM 29%
Mar 2023: Rev ₹314Cr | PAT ₹-67Cr | OPM -12%

## Balance Sheet (Mar 2021)
Total Assets: ₹430 Cr
Total Liabilities: ₹430 Cr
Borrowings: ₹30 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%

## Board
- Parag Suganchand Sancheti, CEO & Executive Director
- Pratibha S. Pilgaonkar, Co-Founder, MD & Director
- Nitin  Jajodia, Chief Financial Officer
- Deepashree  Tanksale, Company Secretary & Compliance Officer
- Sudhir Dhirendra Pilgaonkar, Co-Founder, Chief Commercial Officer & Senior VP

---
Source: rupiya.io/stocks/rubicon
Disclaimer: For research and education only. Not investment advice.